| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/16/1999 | US5882647 Aquatic animal treatment method and composition containing cajeput oil |
| 03/16/1999 | US5882639 Topically treating photodermatitis, thermal burn, decubitus ulcer, or herpes zoster |
| 03/16/1999 | US5882354 Close vascularization implant material |
| 03/16/1999 | US5881926 Pharmaceutical compositions in semisolid form and a device for administration thereof |
| 03/16/1999 | US5881721 Apparatus for orienting and positioning an elongate object for dispensing |
| 03/16/1999 | US5881720 Method of delivering halotherapy |
| 03/16/1999 | CA2172373C Thermally-gelling ophthalmic drug delivery vehicles containing cellulose ethers |
| 03/16/1999 | CA2168248C Antifungal nail solution |
| 03/16/1999 | CA2167570C Flavanolignan preparations with improved liberation and resorbability |
| 03/16/1999 | CA2147362C Topical ophthalmic pharmaceutical vehicles |
| 03/16/1999 | CA2103447C Use of nano particles as pharmaceutical carriers |
| 03/16/1999 | CA2094513C Encapsulated antiperspirant salts and deodorant/ antiperspirants |
| 03/16/1999 | CA2086831C Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them |
| 03/11/1999 | WO1999011798A1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells |
| 03/11/1999 | WO1999011703A1 Cross-linked particles |
| 03/11/1999 | WO1999011695A1 Spherical microparticles containing linear polysaccharides |
| 03/11/1999 | WO1999011645A1 Poly(adp-ribose) polymerase ('parp') inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage |
| 03/11/1999 | WO1999011286A1 Vaginal suppository vaccine for urogenital infections |
| 03/11/1999 | WO1999011272A1 Vitamin d3 analog loaded polymer formulations for cancer and neurodegenerative disorders |
| 03/11/1999 | WO1999011270A1 Pharmaceutical compositions for the treatment of ocular inflammations comprising dexamethasone palmitate |
| 03/11/1999 | WO1999011265A1 Transdermal therapeutic system containing the active substance scopolamine base |
| 03/11/1999 | WO1999011263A1 Combination therapy comprising amlodipine and a statin compound |
| 03/11/1999 | WO1999011261A1 Granules free of excipients |
| 03/11/1999 | WO1999011259A1 Therapeutic combinations comprising amlodipin and atorvastatin |
| 03/11/1999 | WO1999011254A1 Anti-atherosclerotic and anti-thrombotic agent and the use thereof |
| 03/11/1999 | WO1999011248A1 Improved method for preventing crystal formation in a scopolamine transdermal device |
| 03/11/1999 | WO1999011247A1 Biphasic lipid vesicle composition for transdermal administration of an immunogen |
| 03/11/1999 | WO1999011246A1 Improvements in or relating to capsules |
| 03/11/1999 | WO1999011245A1 A pharmaceutical composition having two coating layers |
| 03/11/1999 | WO1999011244A1 Sustained release drug delivery devices |
| 03/11/1999 | WO1999011242A1 Oral liposomal delivery system |
| 03/11/1999 | WO1999011241A1 Oil in water emulsions containing saponins |
| 03/11/1999 | WO1999011240A1 Carotenoid microemulsions |
| 03/11/1999 | WO1999011239A1 Method for preparing pharmaceutical formulations |
| 03/11/1999 | WO1999011232A1 Oral compositions |
| 03/11/1999 | WO1998056360A3 Film-coated tablet for improved upper gastrointestinal tract safety |
| 03/11/1999 | WO1998053797A3 Encapsulation of water insoluble active substances with an amphiphilic character |
| 03/11/1999 | DE19738865A1 Use of oligoglycoside fatty acid esters as emulsifiers |
| 03/11/1999 | DE19738856A1 Treibmittelfreies Verfahren zur Herstellung flächenförmiger Polymerschäume Propellant-free process for the production of sheet-like polymer foams |
| 03/11/1999 | DE19738855A1 Transdermales therapeutisches System mit haftklebender Reservoirschicht und unidirektional elastischer Rückschicht Transdermal therapeutic system with contact adhesive reservoir layer and unidirectional elastic backing |
| 03/11/1999 | DE19738643A1 Transdermales therapeutisches System mit dem Wirkstoff Scopolaminbase Transdermal therapeutic system with the active ingredient scopolamine |
| 03/11/1999 | CA2303200A1 Oral liposomal delivery system |
| 03/11/1999 | CA2302788A1 Improvements in or relating to capsules |
| 03/11/1999 | CA2302523A1 Cross-linked particles |
| 03/11/1999 | CA2302505A1 Vaginal suppository vaccine for urogenital infections |
| 03/11/1999 | CA2302494A1 Biphasic lipid vesicle composition for transdermal administration of an immunogen |
| 03/11/1999 | CA2302346A1 Spherical linear polysaccharide-containing microparticles |
| 03/11/1999 | CA2301325A1 Method for preparing pharmaceutical formulations |
| 03/11/1999 | CA2300850A1 Pharmaceutical compositions for the treatment of ocular inflammations comprising dexamethasone palmitate |
| 03/11/1999 | CA2300676A1 Oral compositions |
| 03/11/1999 | CA2296758A1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells |
| 03/11/1999 | CA2294133A1 Poly(adp-ribose) polymerase ("parp") inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage |
| 03/10/1999 | EP0900582A1 Method for removal of residual organic solvents from a crystalline bulk substance and use thereof in manufacturing pharmaceuticals |
| 03/10/1999 | EP0900576A1 Electrode device for iontophoresis |
| 03/10/1999 | EP0900565A1 Patch containing isosorbide dinitrate |
| 03/10/1999 | EP0900564A1 Long-acting antiseptic vaginal tablet |
| 03/10/1999 | EP0900563A1 Production of pharmaceutical formulations containing aescin for treatment of edema and venous disorders |
| 03/10/1999 | EP0900562A1 Lavage solution for intestinal tract |
| 03/10/1999 | EP0900559A1 Use of a dispersion based on lipid vesicles as an anti-inflammatory composition |
| 03/10/1999 | EP0900281A1 Composition for the transfection of higher eucaryotic cells |
| 03/10/1999 | EP0900076A1 Transdermal device |
| 03/10/1999 | EP0900075A1 Radiation-protective phospholipid |
| 03/10/1999 | EP0863742A4 Silicone containing powders |
| 03/10/1999 | EP0785769B1 Therapeutic vitamin-calcium combination in unitary galenic tablet form, method for preparing same and use thereof |
| 03/10/1999 | EP0773951B1 Dinucleoside-5',5'-pyrophosphates |
| 03/10/1999 | EP0735898B1 Vaccines |
| 03/10/1999 | EP0504372B1 Cosmetic technology |
| 03/10/1999 | EP0153926B2 Microdroplets of water-insoluble drugs |
| 03/10/1999 | CN1210467A Formulation |
| 03/10/1999 | CN1210466A Colonic delivery of nicotine to treat inflammatory bowel disease |
| 03/10/1999 | CN1210464A Aqueous formulation comprising bambuterol and use thereof |
| 03/10/1999 | CN1210463A Transparent aqueous solution of diclofenac sodium and medicinal compositions with the use of the same |
| 03/10/1999 | CN1210462A External preparation containing tranilast and process for producing the same |
| 03/10/1999 | CN1210460A Preparations stimulating nail growth |
| 03/10/1999 | CN1210459A Sustained delivery of active agent using an implantable system |
| 03/10/1999 | CN1210014A External-use ointment for chronic bronchitis and pulmonary emphysema |
| 03/10/1999 | CN1210012A Transcription for defatting health-care products and preparation thereof |
| 03/10/1999 | CN1210000A Ointment for wounds and sores and preparation thereof |
| 03/10/1999 | CN1042397C Swine WBC interferon injection and its preparation |
| 03/10/1999 | CN1042396C Chinese medicinal cream and preparation for treatment of skin scar increament and pigmentation |
| 03/10/1999 | CN1042395C Queen ant extrat oral liquid and its preparation |
| 03/10/1999 | CN1042394C Pharmaceutical composition containing felbinac |
| 03/10/1999 | CA2247011A1 Stabilized pharmaceutical preparation |
| 03/09/1999 | USRE36138 Percutaneous absorption promoter, a tape plaster and a method of promoting percutaneous absorption |
| 03/09/1999 | US5880163 Oil composition of dihydropolyprenols |
| 03/09/1999 | US5880148 Treating diabetes, arterial hypertension, restenosis and atheromatous diseases |
| 03/09/1999 | US5880133 Mixture containing n-methylpyrrolidone and an acid excipient |
| 03/09/1999 | US5880123 Hemolysis prevention by non-ionic surfactants |
| 03/09/1999 | US5880107 Sodium hyaluronate based ophthalmic formulation for use in eye surgery |
| 03/09/1999 | US5880106 Containing water insoluble antacid buffering composition combined with dihydroxyaluminum alkali metal carbonate or calcium carbonate, optional excipients; improved bioavailability, reduced side effects |
| 03/09/1999 | US5880101 Treatment of diseases associated with an impaired energy turnover; stimulating energy conversion in human cells |
| 03/09/1999 | US5880100 Method for inhibiting binding of human lens cells |
| 03/09/1999 | US5879877 Separating motile sperm |
| 03/09/1999 | US5879718 Composition for topical use in the form of a surfactant-free oil-in-water emulsion containing a crosslinked and neutralized poly (2-acrylamido-2-methylpropanesulphonic acid) polymer |
| 03/09/1999 | US5879717 Wound healing compositions containing iodine and sucrose |
| 03/09/1999 | US5879714 Solidified granules of drug, water insoluble polymer and carrier |
| 03/09/1999 | US5879713 Targeted delivery via biodegradable polymers |
| 03/09/1999 | US5879712 Introducing solution comprising alginate and drug into mixing chamber to form droplets, introducing stream of emulsifier, forming emulsion, transporting to second mixing chamber, introducing crosslinking agent to form microparticles |
| 03/09/1999 | US5879711 Stable antiandrogenic gel composition |
| 03/09/1999 | US5879710 Comprising melatonin and melatonin derivatives, acrylic acid polymeric resin, magnesium stearate, lactose diluent, polyvinylpyrrolidinone and cellulose derivatives |